Nxera Pharma Co., Ltd.
SOLTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5 | -$7 | $1 | $0 |
| Dep. & Amort. | $4 | $2 | $1 | $1 |
| Deferred Tax | $0 | $0 | $2 | $3 |
| Stock-Based Comp. | $1 | $1 | $1 | $1 |
| Change in WC | -$6 | $2 | $5 | -$2 |
| Other Non-Cash | -$2 | -$3 | -$1 | $4 |
| Operating Cash Flow | -$8 | -$5 | $10 | $7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$0 | -$0 |
| Net Acquisitions | $0 | -$63 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$0 |
| Inv. Sales/Matur. | $0 | $0 | $1 | $0 |
| Other Inv. Act. | -$5 | -$0 | -$0 | $0 |
| Investing Cash Flow | -$5 | -$64 | $1 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6 | $39 | $0 | $11 |
| Stock Issued | $0 | $10 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$1 | -$5 | -$0 |
| Financing Cash Flow | -$7 | $48 | -$5 | $11 |
| Forex Effect | $3 | $3 | $0 | $2 |
| Net Chg. in Cash | -$17 | -$17 | $6 | $20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $49 | $67 | $60 | $40 |
| End Cash | $32 | $49 | $67 | $60 |
| Free Cash Flow | -$9 | -$6 | $10 | $7 |